Life sciences risk is shifting and coverage may not follow

A new Zurich report finds accountability gaps forming as AI and outcome-based models reshape the sector

Commercial risk teams are responding with tighter controls, scenario modeling, and broader collaboration across underwriting, claims, and cyber operations.

Leaders continue to prioritize resilience planning while balancing cost, coverage terms, and operational exposure in a changing market cycle.